ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PAND Pandion Therapeutics Inc

60.05
0.00 (0.00%)
After Hours
Last Updated: 20:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 59.70
Ask Price 59.90
News -
Company Name Stock Ticker Symbol Market Type
Pandion Therapeutics Inc PAND NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 60.05 20:00:00
Open Price Low Price High Price Close Price Prev Close
60.05 60.05
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 60.05 USD

Pandion Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.77B - - - -55.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Pandion Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PAND Message Board. Create One! See More Posts on PAND Message Board See More Message Board Posts

Historical PAND Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Pandion Therapeutics Description

Pandion Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address the unmet needs of patients suffering from autoimmune diseases. The firm has combined a network-based conceptualization of the immune system in advanced protein engineering to develop TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform. Its pipeline products are PT101, for the treatment of patients with moderate-to-severe ulcerative colitis and the treatment of patients with systemic lupus erythematosus; PT627; PT001; and others.

Your Recent History

Delayed Upgrade Clock